AMDL FILES NEW APPLICATION WITH FDA

AMDL, developer and marketer of tests for the early detection of cancer and other serious diseases, has announced its consultant, Diagnostic Oncology Clinical Research Organization, submitted to the FDA, on behalf of AMDL, additional data and a new application for 510(k) clearance to market AMDL's DR-70 test as an aid in monitoring patients previously diagnosed with progressing colorectal cancer.

Bloomberg (http://quote.bloomberg.com/apps/news?pid=conewsstory&refer=conews&tkr=ADL:US&sid=a_0dlKCXBQl8)